Free Trial

Fractyl Health (GUTS) News Today

Fractyl Health logo
$1.23 -0.07 (-5.38%)
Closing price 03/25/2025 04:00 PM Eastern
Extended Trading
$1.23 +0.00 (+0.08%)
As of 03/25/2025 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Fractyl Health, Inc. stock logo
William Bradley Acquires 16,129 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) Stock
Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) Director William Bradley purchased 16,129 shares of Fractyl Health stock in a transaction that occurred on Thursday, March 13th. The stock was acquired at an average cost of $1.26 per share, with a total value of $20,322.54. Following the acquisition, the director now directly owns 16,129 shares of the company's stock, valued at $20,322.54. The trade was a ∞ increase in their position. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink.
Fractyl Health, Inc. stock logo
Fractyl Health, Inc. (NASDAQ:GUTS) Sees Large Increase in Short Interest
Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) was the target of a significant increase in short interest in February. As of February 15th, there was short interest totalling 3,100,000 shares, an increase of 29.2% from the January 31st total of 2,400,000 shares. Based on an average daily volume of 327,700 shares, the short-interest ratio is currently 9.5 days. Currently, 15.1% of the company's stock are sold short.
Fractyl Health reports Q4 EPS (52c), consensus (44c)
Fractyl Health files $300M mixed securities shelf
Fractyl Health, Inc. stock logo
Fractyl Health (NASDAQ:GUTS) Posts Quarterly Earnings Results, Misses Expectations By $0.08 EPS
Fractyl Health (NASDAQ:GUTS - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.52) earnings per share for the quarter, missing the consensus estimate of ($0.44) by ($0.08).
Fractyl Health, Inc. stock logo
Fractyl Health, Inc. (NASDAQ:GUTS) Sees Significant Decrease in Short Interest
Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) was the recipient of a large drop in short interest during the month of January. As of January 31st, there was short interest totalling 2,400,000 shares, a drop of 12.1% from the January 15th total of 2,730,000 shares. Based on an average daily volume of 355,300 shares, the days-to-cover ratio is presently 6.8 days. Approximately 11.6% of the company's shares are sold short.
Fractyl Health price target lowered to $6 from $13 at BofA
Fractyl Health, Inc. stock logo
Jay David Caplan Sells 22,346 Shares of Fractyl Health, Inc. (NASDAQ:GUTS) Stock
Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) insider Jay David Caplan sold 22,346 shares of the business's stock in a transaction dated Friday, January 31st. The shares were sold at an average price of $1.81, for a total value of $40,446.26. Following the completion of the transaction, the insider now directly owns 153,544 shares of the company's stock, valued at approximately $277,914.64. The trade was a 12.70 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.
Fractyl Health, Inc. stock logo
Insider Selling: Fractyl Health, Inc. (NASDAQ:GUTS) CEO Sells 90,972 Shares of Stock
Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) CEO Harith Rajagopalan sold 90,972 shares of the firm's stock in a transaction that occurred on Friday, January 31st. The stock was sold at an average price of $1.82, for a total transaction of $165,569.04. Following the transaction, the chief executive officer now directly owns 491,329 shares of the company's stock, valued at $894,218.78. This represents a 15.62 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Fractyl Health, Inc. stock logo
Morgan Stanley Lowers Fractyl Health (NASDAQ:GUTS) Price Target to $10.00
Morgan Stanley cut their price objective on Fractyl Health from $18.00 to $10.00 and set an "overweight" rating for the company in a research report on Monday.
Fractyl Health, Inc. (GUTS) Receives a Buy from Morgan Stanley
Fractyl Health announces increased focus on Revita, Rejuva programs
Fractyl Health, Inc. stock logo
Fractyl Health, Inc. (NASDAQ:GUTS) Sees Large Growth in Short Interest
Fractyl Health, Inc. (NASDAQ:GUTS - Get Free Report) saw a large increase in short interest in the month of December. As of December 31st, there was short interest totalling 2,570,000 shares, an increase of 16.3% from the December 15th total of 2,210,000 shares. Based on an average daily volume of 330,200 shares, the short-interest ratio is presently 7.8 days. Approximately 12.5% of the company's shares are sold short.
Fractyl Health, Inc. stock logo
Geode Capital Management LLC Acquires 313,335 Shares of Fractyl Health, Inc. (NASDAQ:GUTS)
Geode Capital Management LLC grew its holdings in shares of Fractyl Health, Inc. (NASDAQ:GUTS - Free Report) by 166.5% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 501,476 shares of the company's stock after buy
Fractyl Health to present new data on Rejuva Smart GLP-1 program
Fractyl Health management to meet virtually with B. Riley
Fractyl Health Reports Q3 2024 Financial Performance
Fractyl Health Unveils Promising Gene Therapy Data
Fractyl Health, Inc. stock logo
Fractyl Health (GUTS) Scheduled to Post Earnings on Tuesday
Fractyl Health (NASDAQ:GUTS) will be releasing earnings after the market closes on Tuesday, November 12, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=641311)
Remove Ads
Get Fractyl Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter.

GUTS Media Mentions By Week

GUTS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GUTS
News Sentiment

1.89

0.79

Average
Medical
News Sentiment

GUTS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GUTS Articles
This Week

1

3

GUTS Articles
Average Week

Remove Ads
Get Fractyl Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for GUTS and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:GUTS) was last updated on 3/26/2025 by MarketBeat.com Staff
From Our Partners